Jameel Nazir
Chertsey, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Anchored Indirect Treatment Comparison Finds Comparable Effects of Pegcetacoplan and Iptacopan in Paroxysmal Nocturnal Haemoglobinuria.
Journal: European journal of haematology
Published: December 06, 2024
Patient Experience of Living With Hemophilia A: A Conceptual Model of Humanistic and Symptomatic Experience in Adolescents, Adults, and Children.
Journal: Journal of health economics and outcomes research
Published: May 16, 2024
Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France.
Journal: Journal of comparative effectiveness research
Published: April 13, 2023
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 27, 2022
Cost-minimization analysis of recombinant factor VIII Fc versus emicizumab for treating patients with hemophilia A without inhibitors in Europe.
Journal: Journal of medical economics
Published: August 22, 2022
Cost-effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.
Journal: European journal of haematology
Published: August 16, 2022
The cost-effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting.
Journal: Journal of comparative effectiveness research
Published: July 07, 2022
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of life.
Journal: European journal of haematology
Published: March 14, 2022
Health-related quality of life, direct medical and societal costs among children with moderate or severe haemophilia in Europe: multivariable models of the CHESS-PAEDs study.
Journal: Orphanet journal of rare diseases
Published: December 01, 2021
Differential humanistic and economic burden of mild, moderate and severe haemophilia in european adults: a regression analysis of the CHESS II study.
Journal: Orphanet journal of rare diseases
Published: December 01, 2021
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study.
Journal: Annals of hematology
Published: November 10, 2021
Characterization and treatment of immune thrombocytopenia in Europe: a qualitative observational study.
Journal: Hematology (Amsterdam, Netherlands)
Published: November 01, 2021
Last Updated: 09/26/2026